Melanotan II: MC Receptor Agonism in Preclinical Research
What is Melanotan II?
Melanotan II (MT-2) is a synthetic, cyclic analogue of alpha-melanocyte-stimulating hormone (α-MSH). Its cyclic structure makes it more stable and more potent than the natural hormone, and it acts as a non-selective agonist across the melanocortin receptor family.
It is studied as a research tool for probing melanocortin-receptor pharmacology — a receptor system involved in a notably broad range of physiological pathways.
Melanocortin receptor agonism
Non-selective agonism. Melanotan II activates multiple melanocortin receptors (MC1R through MC5R). In preclinical research, MC1R activation is associated with the pigmentation pathway (melanogenesis), while MC3R and MC4R are studied for their roles in energy homeostasis and other central pathways.
Research interest in receptor selectivity. Because MT-2 engages several receptors at once, it is frequently used as a reference agonist in studies aiming to characterise or distinguish the individual contributions of MC3R and MC4R — a central question in melanocortin research.
Velox Peptides supply information
Velox Peptides supplies Melanotan II as a lyophilised powder at ≥99.3% HPLC-verified purity with a batch certificate of analysis available on request. For reconstitution, see the reconstitution calculator. Supplied strictly as a research reagent for in vitro use.
References & further reading
- Hadley ME, Dorr RT. “Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization.” Peptides, 2006.
- Wikberg JE et al. “New aspects on the melanocortins and their receptors.” Pharmacological Research, 2000.
Summaries are paraphrased from the peer-reviewed literature. For full source citations, email veloxpeps@gmail.com.